Cancer Patients Cumulatively Saved Around Rs 294 Crore Due To Price Control: JP Nadda

New Delhi: The government makes all efforts to ensure affordable and accessible treatment is available for cancer patients amid a rise in cases in India, Health Minister JP Nadda said on Friday.

Replying to supplementary questions during Question Hour in the Lok Sabha, Nadda said the government made all efforts to ensure that affordable and accessible treatment was available to the patients.

“The number of cancer cases is going up, it is increasing by almost 2.5 per cent every year,” Nadda said.

In men, cases of oral and lung cancer are on the up while more women are getting breast cancer, he added.

More than 1.55 million cancer cases are being registered every year, Nadda said.

“There is a list of 131 essential cancer medicines, which are in Schedule 1, (that) are monitored and (their) pricing is decided by the government. These are the commonly used medicines,” Nadda said.

He said patients cumulatively saved around Rs 294 crore due to this price control.

“There are 28 combinations, which are not in this list but the NPPA (National Pharmaceutical Pricing Authority) and the government have controlled their pricing as well,” he said.

“We have tried to make cancer drugs affordable,” he added.

Responding to another question on healthcare infrastructure, Nadda said the government was apprised of the matter and expansion of medical colleges were happening so that there could be more doctors.

“There should be a balance in quality and quantity of medical education. We are trying to go as fast as we can but, at the same time, (we) do not want to compromise on the quality of medical doctors,” he said.

Nadda informed the House that the number of medical colleges had gone up from 387 in 2014 to 731 at present while the number of MBBS seats rose from 51,348 seats to 1,12,112 (1.12 lakh) during the same period.

The number of postgraduate seats for medical students has gone up from 31,185 in 2014 to 72,627 at present, he added.

Related Posts

India curbs supply of IVF consumables to unregistered clinics

The move comes amid growing concerns over the proliferation of fertility centres in India, one of the world’s fastest-growing IVF markets. New Delhi: India is moving to cut off supplies…

Maha FDA seizes counterfeit skincare products; FIR registered

Pune: The Food and Drug Administration (FDA), Maharashtra, has seized 12 counterfeit bottles of the popular skincare product Cetaphil Gentle Skin Cleanser from a retailer in Shivajinagar. The incident took…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India curbs supply of IVF consumables to unregistered clinics

India curbs supply of IVF consumables to unregistered clinics

Maha FDA seizes counterfeit skincare products; FIR registered

Maha FDA seizes counterfeit skincare products; FIR registered

RMSCL MD Inspects Rajasthan Sampark Portal; Directs Prompt Resolution of Medicine-Related Grievances

RMSCL MD Inspects Rajasthan Sampark Portal; Directs Prompt Resolution of Medicine-Related Grievances

4 arrested in blood plasma adulteration racket

4 arrested in blood plasma adulteration racket

159 drug samples fail CDSCO quality test in May, 1 flagged spurious

159 drug samples fail CDSCO quality test in May, 1 flagged spurious

Kerala HC upholds DC’s move against vague discount boards; dismisses chemists’ petitions

Kerala HC upholds DC’s move against vague discount boards; dismisses chemists’ petitions